LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 929 | 1057 | 3228 | 0.3277 | 0.0559 |
Hs 578T | GSK1059615 | 3.33 | uM | LJP6 | 72 | hr | 929 | 1302 | 3228 | 0.4035 | 0.1624 |
Hs 578T | GSK1904529A | 3.33 | uM | LJP6 | 72 | hr | 929 | 3087 | 3228 | 0.9565 | 0.9389 |
Hs 578T | Omipalisib | 3.33 | uM | LJP6 | 72 | hr | 929 | 940 | 3228 | 0.2914 | 0.0050 |
Hs 578T | GSK 690693 | 3.33 | uM | LJP5 | 72 | hr | 929 | 2298 | 3228 | 0.7119 | 0.5954 |
Hs 578T | GW843682X | 3.33 | uM | LJP6 | 72 | hr | 929 | 847 | 3228 | 0.2624 | -0.0358 |
Hs 578T | HG-5-113-01 | 3.33 | uM | LJP5 | 72 | hr | 929 | 1400 | 3228 | 0.4339 | 0.2051 |
Hs 578T | HG-5-88-01 | 3.33 | uM | LJP6 | 72 | hr | 929 | 2708 | 3228 | 0.8390 | 0.7739 |
Hs 578T | Imatinib | 3.33 | uM | LJP6 | 72 | hr | 929 | 3546 | 3228 | 1.0987 | 1.1386 |
Hs 578T | JNK-9L | 3.33 | uM | LJP6 | 72 | hr | 929 | 1294 | 3228 | 0.4011 | 0.1590 |
Hs 578T | JW-7-24-1 | 3.33 | uM | LJP6 | 72 | hr | 929 | 1750 | 3228 | 0.5421 | 0.3570 |
Hs 578T | Lapatinib | 3.33 | uM | LJP6 | 72 | hr | 929 | 3262 | 3228 | 1.0105 | 1.0148 |
Hs 578T | LDN-193189 | 3.33 | uM | LJP5 | 72 | hr | 929 | 2511 | 3228 | 0.7781 | 0.6884 |
Hs 578T | Linifanib | 3.33 | uM | LJP6 | 72 | hr | 929 | 3085 | 3228 | 0.9558 | 0.9379 |
Hs 578T | Linsitinib | 3.33 | uM | LJP5 | 72 | hr | 929 | 3132 | 3228 | 0.9702 | 0.9582 |
Hs 578T | Mitoxantrone | 3.33 | uM | LJP5 | 72 | hr | 929 | 530 | 3228 | 0.1643 | -0.1735 |
Hs 578T | Mitoxantrone | 3.33 | uM | LJP6 | 72 | hr | 929 | 550 | 3228 | 0.1706 | -0.1647 |
Hs 578T | MK2206 | 3.33 | uM | LJP6 | 72 | hr | 929 | 2157 | 3228 | 0.6683 | 0.5342 |
Hs 578T | Neratinib | 3.33 | uM | LJP5 | 72 | hr | 929 | 1619 | 3228 | 0.5018 | 0.3003 |
Hs 578T | Nilotinib | 3.33 | uM | LJP5 | 72 | hr | 929 | 3664 | 3228 | 1.1353 | 1.1899 |
Hs 578T | Nintedanib | 3.33 | uM | LJP6 | 72 | hr | 929 | 1395 | 3228 | 0.4323 | 0.2028 |
Hs 578T | NU7441 | 3.33 | uM | LJP5 | 72 | hr | 929 | 2195 | 3228 | 0.6801 | 0.5508 |
Hs 578T | Dactolisib | 3.33 | uM | LJP5 | 72 | hr | 929 | 1177 | 3228 | 0.3646 | 0.1078 |
Hs 578T | NVP-TAE684 | 3.33 | uM | LJP6 | 72 | hr | 929 | 1207 | 3228 | 0.3739 | 0.1208 |
Hs 578T | Palbociclib | 3.33 | uM | LJP6 | 72 | hr | 929 | 1645 | 3228 | 0.5096 | 0.3114 |